Zobrazeno 1 - 10
of 515
pro vyhledávání: '"S. Brose"'
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Prevalence of youth nicotine vaping has increased, heightening concerns around negative health effects. This study aimed to compare self-reported respiratory symptoms among youth by vaping behaviours. Methods Participants (n = 39,
Externí odkaz:
https://doaj.org/article/9a8c03aff872413e859dc6b09626f569
Autor:
Andrew G Gianoukakis, Jennifer H Choe, Daniel W Bowles, Marcia S Brose, Lori J Wirth, Taofeek Owonikoko, Svetlana Babajanyan, Francis P Worden
Publikováno v:
European Thyroid Journal, Vol 13, Iss 1, Pp 1-13 (2024)
Background: The optimal timing for initiating multi-kinase inhibitors (MKIs) in patients with radioactive iodine-refractory (RAI-R) differentiated thyroid cancer (DTC) remains unclear. Thus, we evaluated the real-world practice patterns and outcomes
Externí odkaz:
https://doaj.org/article/4362b3a229454c4c935fbc2568fe4ec8
Autor:
Bernadett E. Tildy, Ann McNeill, John Robins, Alexandru Dregan, Sol Richardson, Leonie S. Brose
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background Electronic health records (EHRs) could identify long-term health effects of nicotine vaping. We characterised the extent to which vaping is recorded in primary care EHRs in the UK, on a population level. Methods We performed descr
Externí odkaz:
https://doaj.org/article/6825eabb066542faa315bc240b6c1f4a
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Rates of diseases and death from tobacco smoking are substantially higher among those with a mental health condition (MHC). Vaping can help some people quit smoking, but little is known about vaping among people with MHCs or psych
Externí odkaz:
https://doaj.org/article/fad1936c7bce4701898aac82a9746d40
Autor:
Razvan Cristescu, Andrey Loboda, Robert Orlowski, Vicky Makker, Matthew H Taylor, Carol Aghajanian, Petar Jelinic, Lea Dutta, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, Mark J Messing
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background Lenvatinib plus pembrolizumab demonstrated clinically meaningful benefit in patients with previously treated advanced endometrial carcinoma in Study 111/KEYNOTE-146 (NCT02501096). In these exploratory analyses from this study, we evaluated
Externí odkaz:
https://doaj.org/article/1aba98f370d441fabd9fdd926cef1538
Autor:
Matthew H. Taylor, Sophie Leboulleux, Yury Panaseykin, Bhavana Konda, Christelle de LaFouchardiere, Brett G. M. Hughes, Andrew G. Gianoukakis, Young Joo Park, Ilia Romanov, Monika K. Krzyzanowska, Diana Garbinsky, Bintu Sherif, Jie Janice Pan, Terri A. Binder, Nicholas Sauter, Ran Xie, Marcia S. Brose
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4332-4342 (2023)
Abstract Background In the phase 2 double‐blind Study 211, a starting dose of lenvatinib 18 mg/day was compared with the approved starting dose of 24 mg/day in patients with radioiodine‐refractory differentiated thyroid cancer (RR‐DTC). Predefi
Externí odkaz:
https://doaj.org/article/dc0ec1a8bab345c086c5e789e1eef9a5
Publikováno v:
BMC Primary Care, Vol 24, Iss 1, Pp 1-61 (2023)
Abstract Background Internationally, there is an ‘evidence-practice gap’ in the rate healthcare professionals assess tobacco use and offer cessation support in clinical practice, including primary care. Evidence is needed for implementation strat
Externí odkaz:
https://doaj.org/article/1c977cd2e0e94057a598a56adcbd91b5
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Background Smoking is a major risk factor for cardiovascular disease and smoking cessation reduces excess risk. E-cigarettes are popular for smoking cessation but there is little evidence on their cardiovascular health effect. Our objective
Externí odkaz:
https://doaj.org/article/66b7cda6cbb84d668926d676df503ff2
Autor:
James C. H. Yang, Marcia S. Brose, Gilberto Castro, Edward S. Kim, Ulrik N. Lassen, Serge Leyvraz, Alberto Pappo, Fernando López-Ríos, John A. Reeves, Marc Fellous, Frédérique Penault-Llorca, Erin R. Rudzinski, Ghazaleh Tabatabai, Gilles Vassal, Alexander Drilon, Jonathan Trent
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Tropomyosin receptor kinase (TRK) fusion proteins resulting from neurotrophic tyrosine receptor kinase (NTRK) gene fusions are rare primary oncogenic drivers in a wide array of tumors. Larotrectinib is a first-in-class, highly sel
Externí odkaz:
https://doaj.org/article/d03b60bd6de0450a90283154c262afe5
Autor:
M. S. Brose, Yu. Panaseykin, B. Konda, C. de la Fouchardiere, B. G.M. Hughes, A. G. Gianoukakis, Y. J. Park, I. Romanov, M. K. Krzyzanowska, S. Leboulleux, T. A. Binder, C. Dutcus, R. Xie, M. H. Taylor
Publikováno v:
Опухоли головы и шеи, Vol 12, Iss 1, Pp 86-98 (2022)
Введение. Ленватиниб является мультикиназным ингибитором, одобренным для лечения радиойодрефрактерного дифференцированного рака щит
Externí odkaz:
https://doaj.org/article/d7a35ee1dee346c98829477eec0b69b8